-
ABOUT USHebei Guangxiang Pharmaceutical Co., Ltd. is specializing in the production of bulk pharmaceuticals, fine pharmaceuticals, intermediate compounds and biopharmaceutical preparations.
-
News CenterAt the forefront of corporate development, we champion the positive energy of the Four Pharmaceutical Companies: fulfilling our duties conscientiously, stepping up to the plate and taking proactive action, embracing new missions, and conducting effective new publicity. In doing so, we aim to enhance the overall competence of our employees, stimulate their enthusiasm, initiative, and creativity, and provide robust ideological guidance and powerful spiritual strength to drive the enterprise forward.
-
INNOVATIONDevelops fine, series, high-end bulk pharmaceutical intermediates and innovative bulk pharmaceutical intermediates with high added value to build variety competition advantages.
-
-
RECRUITGuangxiang has jointly established engineering laboratories, technology research centers and other high-level innovation platforms with CAS, Zhejiang University, Tianjin University and other universities.
-
CONTACTWith stable production, high-quality and reliable service, the company's products have been sold to more than 80 countries such as the United States, the United Kingdom, Germany and the Netherlands
Guangxiang Pharmaceutical of Shijiazhuang Sihua Pharmaceutical Group Honored by the Cangzhou Lingang Economic Development Zone
Category:
TIME：2025-02-28
On February 28, the Cangzhou Lingang Economic and Technological Development Zone held a mobilization conference and summary-and-award ceremony for high-quality development in 2025, at which enterprises that have made outstanding contributions to the zone’s high-quality development were solemnly commended. Hebei Guangxiang Pharmaceutical Co., Ltd. of Shijiazhuang Sihua Pharmaceutical Group was awarded the title of “Leading Enterprise in Scientific and Technological Innovation.”
In his address as the representative of the honored enterprise, Cui Yongbin, Chairman of Guangxiang Pharmaceutical, stated that the company has proactively seized the strategic opportunities presented by the Beijing–Tianjin–Hebei coordinated development initiative. With strong support from the Lingang Development Zone, Guangxiang Pharmaceutical has taken innovation-driven development as its guiding principle, accelerated the growth of new-quality productive forces, continuously enhanced its integrated “API-plus-formulation” development capabilities, and focused on expanding both domestic and international markets, thereby consistently making new strides in innovative, high-quality corporate development. Currently, Guangxiang Pharmaceutical is undertaking four provincial-level research projects and three municipal-level projects, with more than 70 ongoing projects being expedited, leading to a significant enhancement of its technological strength and laying a solid foundation for the establishment of a national-level enterprise technology center (sub-center). In 2024, 14 specially formulated APIs that have received R&D approval were successfully commercialized and implemented, injecting fresh momentum into the company’s high-quality development. Cui Yongbin emphasized that the company’s growth is inseparable from the park’s favorable innovation ecosystem and conducive development environment. Looking ahead, Guangxiang Pharmaceutical will continue to increase its R&D investment, pursue innovation and strive for higher standards, accelerate its global expansion, and endeavor to build itself into a first-class domestic manufacturer of specialty APIs.
At the meeting, Zhang Jianhua, Secretary of the Party Leadership Group and Director of the Management Committee of the Cangzhou Lingang Economic and Technological Development Zone, solemnly pledged on behalf of all Party members and cadres in the Lingang Industrial Park that optimizing the business environment would be treated as a “never-ending” major project, with unwavering commitment to refraining from unnecessary interference while ensuring prompt response to legitimate requests. He urged all departments to achieve zero-distance communication between government and enterprises, eliminate all obstacles to policy implementation, ensure full and timely provision of essential resources, resolve issues without delay, and adopt zero tolerance for any behavior that undermines the business environment. He emphasized the need to steadfastly place project development at the “center stage,” to deliver first-class services to enterprises, to encourage enterprises to strive for leadership, and to continuously build a world-class business environment that inspires state-owned enterprises to take bold action, private enterprises to innovate boldly, and foreign-invested enterprises to invest boldly.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
E-mail: hbgxzy@hebgxzy.com
Address: The west of Jingliu Road, lingang economic nad technological development zone, cangzhou city, Hebei province
Website
Official WeChat
e-Home
